Wegovy needle length: what the official guidance says and why it matters

Why 4 mm became the standard: what the research on subcutaneous depth tells us

The choice of 4 mm is not arbitrary. Research into subcutaneous tissue depth across adults with a wide range of body compositions has consistently found that skin thickness (not total fat depth) is the relevant variable for needle penetration, and skin thickness in the typical injection sites (abdomen, thigh, upper arm) averages between 1.8 mm and 2.4 mm in most adults. A 4 mm needle therefore clears the skin layer and sits in subcutaneous fat without approaching the muscle fascia beneath, even when no skin fold is raised.

This evidence base is why the major pen manufacturers moved away from longer needles (8 mm, then 6 mm were once common for subcutaneous insulin) toward the 4 mm standard now used in most modern pre-filled GLP-1 pens. The NHS patient information for semaglutide directs users to inject into subcutaneous tissue and to follow the instructions that come with the pen, rather than specifying a separate needle or technique adjustment based on body size.

Muscle injection is the risk the 4 mm length guards against. Injecting into muscle rather than fat can alter the absorption rate of the medicine and increases the chance of localised pain and bruising. At 4 mm, perpendicular to uncompressed skin, intramuscular injection is unlikely in all but very lean individuals, and for that small group, raising a skin fold provides additional margin.

Technique has more effect on your experience than the needle's length

Most injection discomfort with the Wegovy pen comes from technique, not the needle itself. The 32-gauge diameter is finer than many standard blood-test needles; most people describe the sensation as a brief pressure rather than a sting. What tends to amplify that sensation is injecting cold medicine straight from the fridge, pressing the pen against the skin at an angle, or tensing the muscle underneath.

Letting the pen sit at room temperature for around 30 minutes before use is one of the consistently cited tips in the patient information leaflet, cold semaglutide solution is more viscous and can feel sharper on delivery. When you are ready, press the pen flat against the skin at 90 degrees and hold it there; the Wegovy pen is designed to release the needle and deliver the dose automatically when you press the button. There is no need to pull the skin taut or pinch a fold for most people at 4 mm.

If you want to understand the full step-by-step process for the Wegovy pen's injection mechanism, that page walks through each stage in detail. Site rotation is equally important: the same small patch of skin injected week after week can develop lipohypertrophy (a thickening that slows absorption) so keep a mental or written map of where you last injected.

Storage, disposal and the question of spare needles

The Wegovy pen comes with its needle pre-attached for each dose, so there is no separate needle to source or attach in the way some insulin pen users manage. Once you have completed the injection, the needle sleeve locks and the pen should be discarded. Reusing a needle blunts the tip, increases injection discomfort, and raises the risk of infection and blocked delivery.

Safe disposal is a practical detail people sometimes leave until the last minute, and a sharps bin full to the brim at a bank holiday weekend is an avoidable problem. A 1-litre sharps container takes used Wegovy pens and should be sealed and returned to a pharmacy for disposal when three-quarters full. Your local pharmacy or GP surgery can advise on your area's collection arrangements; some councils also run household collection services.

The pen itself is stored in the fridge between 2°C and 8°C. If you need to travel or the pen has been out of the fridge, the exact room-temperature window is stated in the patient information leaflet included with your medicine, always defer to that document rather than any figure quoted online, since storage guidance is product-batch specific. For a broader look at everything covered by Wegovy needles, including compatibility questions, that page goes into more detail.

When the needle length question comes up during treatment

Prescribers occasionally hear this question from people who have previously used insulin pens or other injectable medicines and assumed they would need to source separate needles at different lengths. If you are curious about how long a Wegovy needle actually is and why that measurement is fixed across all dose strengths, that page explains the detail clearly. The pen design and needle specification do not change as the dose escalates; only the volume of medicine delivered changes. If you are moving through the titration schedule and want to understand the full picture of how Wegovy works as a treatment, including what the dose schedule looks like over time, that page covers the licensed pathway in full.

A note on cost: if you are thinking about what private treatment looks like financially, the Wegovy prices page sets out what a legitimate private prescription includes. One transparent price covers consultation, clinical review, the medicine and delivery, no separate line for needles or aftercare.

If questions remain after reading, our prescribers are the right people to answer them. Speak to our prescribers through a free consultation and get a same-day clinical review from a GPhC-registered Independent Prescriber, not an automated triage system.